Consistent with this hypothesis is evidence for consumption of C1-INH, one of the major inhibitors of complement, coagulation and kinin cascades (24, 25), in cancer patients with COVID-19 and elevated D-dimers. The gene discussed is SERPING1; the disease is cancer.